GALECTIN THERAPEUTICS INC. Increase (Decrease) in Restricted Cash
GALECTIN THERAPEUTICS INC. (GALT) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2016-03-15
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2012-12-31 was -$59.00K, a 1280.00% decline year-over-year.
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2012-09-30 was -$10.00K.
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2012-06-30 was $0.00.
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for the quarter ending 2012-03-31 was $0.00.
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2015 was $0.00.
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2014 was $0.00.
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2013 was $0.00.
- GALECTIN THERAPEUTICS INC. increase (decrease) in restricted cash for fiscal 2012 was -$69.00K, a 790.00% decline from fiscal 2011.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 132 month | Increase (Decrease) in Restricted Cash 135 month | Increase (Decrease) in Restricted Cash 138 month | Increase (Decrease) in Restricted Cash 141 month | Increase (Decrease) in Restricted Cash 144 month | Increase (Decrease) in Restricted Cash 147 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-15 | |||||||||
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 | |||||||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 | |||||||||
| 2012-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | -$69.00K derived: sum of 2 quarters · filed 2015-03-18 | -$69.00K derived: sum of 3 quarters · filed 2015-03-18 | -$69.00K 10-K · filed 2015-03-18 | ||||||
| 2012-09-30 | -$10.00K derived: 10-Q 147 month − 10-Q 144 month · filed 2012-11-09 | -$10.00K derived: sum of 2 quarters · filed 2012-11-09 | -$10.00K 10-Q · filed 2013-11-12 | -$5.00K derived: sum of 4 quarters · filed 2013-03-29 | $59.00K 10-Q · filed 2012-11-09 | |||||
| 2012-06-30 | $0.00 derived: 10-Q 144 month − 10-Q 141 month · filed 2012-08-10 | $0.00 derived: sum of 2 quarters · filed 2012-08-10 | $5.00K derived: sum of 3 quarters · filed 2013-03-29 | $5.00K derived: sum of 4 quarters · filed 2013-03-29 | $69.00K 10-Q · filed 2012-08-10 | |||||
| 2012-03-31 | $0.00 derived: 10-Q 141 month − 10-K 138 month · filed 2012-05-11 | $5.00K derived: sum of 2 quarters · filed 2013-03-29 | $5.00K derived: sum of 3 quarters · filed 2013-03-29 | $69.00K 10-Q · filed 2012-05-11 | ||||||
| 2011-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $5.00K derived: sum of 2 quarters · filed 2013-03-29 | $10.00K 10-K · filed 2013-03-29 | $69.00K 10-K · filed 2012-03-30 | ||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $5.00K 10-Q · filed 2012-11-09 | $64.00K 10-Q · filed 2011-11-10 | |||||||
| 2011-06-30 | $5.00K 10-Q · filed 2012-08-10 | $64.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |